Farther Finance Advisors’s Caribou Biosciences CRBU Stock Holding History

Farther Finance Advisors’s Portfolio CRBU Stock Details CRBU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176	Hold	100	–	–	﹤0.01%	5736
2026 Q1	$199	Hold	100	–	–	﹤0.01%	5433
2025 Q4	$159	Hold	100	–	–	﹤0.01%	5244
2025 Q3	$233	Hold	100	–	–	﹤0.01%	4693
2025 Q2	$126	Hold	100	–	–	﹤0.01%	4280
2025 Q1	$84	Hold	100	–	–	﹤0.01%	4089
2024 Q4	$159	Hold	100	–	–	﹤0.01%	3707
2024 Q3	$196	Hold	100	–	–	﹤0.01%	3657
2024 Q2	$159	Sell	100 -377	-79%	-$1.21K	﹤0.01%	3526
2024 Q1	$2.41K	Sell	477 -5	-1%	-$31	﹤0.01%	2405
2023 Q4	$2.76K	Buy	482 +382	+382%	+$1.89K	﹤0.01%	2286
2023 Q3	$478	Hold	100	–	–	﹤0.01%	2284
2023 Q2	$425	Hold	100	–	–	﹤0.01%	2195
2023 Q1	$531	Hold	100	–	–	﹤0.01%	1993
2022 Q4	$628	Buy	+100	New	+$890	﹤0.01%	1785

Other funds holding CRBU

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $636M AUM 22.1% 1-Year Est. Return

TWM

Thrive Wealth Management Audubon, Pennsylvania $787M AUM 23.6% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JWCA

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

NWS

Nvest Wealth Strategies Powell, Ohio $160M AUM

FFO

Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors's CRBU Position: Q2 2026 in Review

Farther Finance Advisors held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 100 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #5736.

Farther Finance Advisors first reported a position in CRBU in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.76K in Q4 2023. 10 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

Farther Finance Advisors held 100 shares of Caribou Biosciences worth $176 as of Q2 2026.
Farther Finance Advisors left its Caribou Biosciences share count unchanged in Q2 2026.
Caribou Biosciences made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5736 holding.
Farther Finance Advisors first reported a position in Caribou Biosciences in Q4 2022 and has held it in 15 quarters since.
Farther Finance Advisors's Caribou Biosciences position peaked at $2.76K in Q4 2023.
10 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.